A new treatment approach for people with early-stage rectal cancer could change the way the disease is treated. Results from ...

A landmark trial finds chemoradiotherapy could help four in five early-stage rectal cancer patients avoid major surgery.

A new trial of patients with advanced rectal cancer has found that the addition of immunotherapy treatment alongside extended radiotherapy led to better rates of remission. The findings from the ...

Immune checkpoint inhibitors (ICIs) have revolutionized the field of cancer immuno-oncology. ICIs act on cancer cells by blocking the interaction between immune checkpoint proteins on immune cells and ...

Memorial Sloan Kettering Cancer Center personalizes care, aiming to improve patients’ quality of life. Colorectal cancer, which includes cancer of both the colon and the rectum, is the third most ...

Priority review reflects AZUR-1 meeting its primary end point of meaningful, sustained 12-month cCR in dMMR/MSI-H stage ...

New cancer research pioneered by Memorial Sloan Kettering points to a strong alternative to chemotherapy, surgery, and radiation for some forms of cancer. Nearly 80% of patients who suffered from a ...

(This Aug 28 story has been repeated with no changes to text.) By Bhanvi Satija and Sriparna Roy Aug 28 (Reuters) - BioNTech ...

Colorectal cancer is a type of cancer that starts in the colon or rectum, which are the last parts of the digestive system that helps remove waste from the body. It usually begins as a small growth or ...

She was doing everything right. She exercised, ate well, and stayed active with her husband and two teenage daughters. She ...